The mechanism of action of GLP-1RA to promote weight loss mainly includes the reduction of fat deposition through regulation of adipose tissue (lipolysis, fatty acid oxidation, and adipocyte differentiation) and the reduction of food intake through the central and peripheral nervous system
Insert the needle at a 45 to 90-degree angle (90 degrees for most people with adequate subcutaneous tissue)
Some people are exceptional responders to semaglutide and may achieve 20%+ loss
Zepbound (tirzepatide) FDA-approved for chronic weight management using the same BMI criteria, and, since December 20, 2024, for moderate-to-severe obstructive sleep apnea in adults with obesity
"I'm worried about compounded medication quality." It's the most common concern and a reasonable one with a specific answer available if you ask for it
doi:10.1155/2024/8056440 Waldrop SW, Johnson VR, Stanford FC